Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Determination of vitamins K1 , MK-4, and MK-7 in human serum of postmenopausal women by HPLC with fluorescence detection

E. Klapkova, J. Cepova, K. Dunovska, R. Prusa,

. 2018 ; 32 (5) : e22381. [pub] 20180115

Language English Country United States

Document type Journal Article

BACKGROUND: New high-performance liquid chromatography (HPLC) method was developed for the determination of vitamin K1 and two forms of vitamin K2 (MK-4 and MK-7) in human serum, and the levels of vitamin K were determined in 350 samples of postmenopausal women. METHODS: Vitamin K was determined by HPLC with fluorescence detection after postcolumn zinc reduction. The detection was performed at 246 nm (excitation) and 430 nm (emission). The internal standard and 2 mL of ethanol were added to 500 μL of serum. The mixture was extracted with 4 mL of hexane, and solid phase extraction was then used. RESULTS: The HLPC method was fully validated. The intra- and interday accuracy and precision were evaluated on two QC samples by multiple analysis, and CV were less than 10%. The limit of quantification for MK-4 was found at 0.04 ng/mL, for K1 0.03 ng/mL, and for MK-7 0.03 ng/mL. The mean recoveries of the corresponding compounds were 98%-110%. Serum levels of MK-4, K1 , and MK-7 in postmenopausal women with osteoporosis were 0.890 ± 0.291 ng/mL, 0.433 ± 0.394 ng/mL, and 1.002 ± 1.020 ng/mL, respectively (mean ± SD). Serum levels of MK-4, K1 , and MK-7 in postmenopausal women without osteoporosis were 0.825 ± 0.266 ng/mL, 0.493 ± 0.399 ng/mL, and 1.186 ± 1.076 ng/mL, respectively (mean ± SD). CONCLUSION: New HPLC method for the determination of vitamins K1 , MK-4, and MK-7 in serum was evaluated and validated. This method is highly specific and sensitive with the low limit of quantification.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000985
003      
CZ-PrNML
005      
20190122094430.0
007      
ta
008      
190107s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jcla.22381 $2 doi
035    __
$a (PubMed)29333616
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Klapkova, Eva $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
245    10
$a Determination of vitamins K1 , MK-4, and MK-7 in human serum of postmenopausal women by HPLC with fluorescence detection / $c E. Klapkova, J. Cepova, K. Dunovska, R. Prusa,
520    9_
$a BACKGROUND: New high-performance liquid chromatography (HPLC) method was developed for the determination of vitamin K1 and two forms of vitamin K2 (MK-4 and MK-7) in human serum, and the levels of vitamin K were determined in 350 samples of postmenopausal women. METHODS: Vitamin K was determined by HPLC with fluorescence detection after postcolumn zinc reduction. The detection was performed at 246 nm (excitation) and 430 nm (emission). The internal standard and 2 mL of ethanol were added to 500 μL of serum. The mixture was extracted with 4 mL of hexane, and solid phase extraction was then used. RESULTS: The HLPC method was fully validated. The intra- and interday accuracy and precision were evaluated on two QC samples by multiple analysis, and CV were less than 10%. The limit of quantification for MK-4 was found at 0.04 ng/mL, for K1 0.03 ng/mL, and for MK-7 0.03 ng/mL. The mean recoveries of the corresponding compounds were 98%-110%. Serum levels of MK-4, K1 , and MK-7 in postmenopausal women with osteoporosis were 0.890 ± 0.291 ng/mL, 0.433 ± 0.394 ng/mL, and 1.002 ± 1.020 ng/mL, respectively (mean ± SD). Serum levels of MK-4, K1 , and MK-7 in postmenopausal women without osteoporosis were 0.825 ± 0.266 ng/mL, 0.493 ± 0.399 ng/mL, and 1.186 ± 1.076 ng/mL, respectively (mean ± SD). CONCLUSION: New HPLC method for the determination of vitamins K1 , MK-4, and MK-7 in serum was evaluated and validated. This method is highly specific and sensitive with the low limit of quantification.
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    12
$a fluorescence $7 D005453
650    _2
$a lidé $7 D006801
650    _2
$a postmenopauza $x krev $7 D017698
650    _2
$a časové faktory $7 D013997
650    _2
$a vitamin K 1 $x krev $7 D010837
650    _2
$a vitamin K 2 $x krev $x klasifikace $7 D024482
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cepova, Jana $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Dunovska, Katerina $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Prusa, Richard $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
773    0_
$w MED00009990 $t Journal of clinical laboratory analysis $x 1098-2825 $g Roč. 32, č. 5 (2018), s. e22381
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29333616 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190122094649 $b ABA008
999    __
$a ok $b bmc $g 1363973 $s 1039108
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 32 $c 5 $d e22381 $e 20180115 $i 1098-2825 $m Journal of clinical laboratory analysis $n J Clin Lab Anal $x MED00009990
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...